DVA (DaVita) Cyclically Adjusted PS Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DVA DaVita Inc DVA
91 GF Score
Price $183.86
GF Value $196.07
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is DaVita Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


DaVita  (NYSE:DVA) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


DaVita Cyclically Adjusted PS Ratio Related Terms


DaVita Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for DaVita's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DaVita Cyclically Adjusted PS Ratio Chart

DaVita Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.52 0.87 1.10 1.43 0.98

DaVita Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.25 1.13 0.95 1.23 1.72

DVA vs EHC, UHS, ENSG: Cyclically Adjusted PS Ratio Comparison

For the Medical Care Facilities subindustry, DaVita's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaVita Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where DaVita's Cyclically Adjusted PS Ratio falls into.


DVA
91GF Score
DaVita Inc DVA
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DaVita Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

DaVita's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, DaVita's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=53.775/333.9520*333.9520
=53.775

Current CPI (Jun. 2026) = 333.9520.

DaVita Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 18.025 241.428 24.933
201612 18.886 241.432 26.123
201703 13.474 243.801 18.456
201706 13.915 244.955 18.971
201709 14.446 246.819 19.546
201712 15.046 246.524 20.382
201803 15.671 249.554 20.971
201806 16.582 251.989 21.976
201809 17.023 252.439 22.520
201812 16.946 251.233 22.526
201903 16.447 254.202 21.607
201906 17.043 256.143 22.220
201909 19.195 256.759 24.966
201912 22.211 256.974 28.864
202003 22.390 258.115 28.968
202006 23.213 257.797 30.070
202009 23.590 260.280 30.267
202012 25.055 260.474 32.123
202103 24.769 264.877 31.228
202106 26.175 271.696 32.173
202109 26.751 274.310 32.567
202112 28.080 278.802 33.635
202203 28.035 287.504 32.564
202206 29.935 296.311 33.738
202209 31.617 296.808 35.574
202212 31.736 296.797 35.709
202303 31.062 301.836 34.367
202306 32.118 305.109 35.154
202309 33.191 307.789 36.012
202312 33.905 306.746 36.912
202403 33.911 312.332 36.258
202406 35.826 314.175 38.081
202409 38.039 315.301 40.289
202412 39.291 315.605 41.575
202503 39.662 319.799 41.417
202506 43.685 322.561 45.228
202509 46.364 324.800 47.670
202512 50.796 324.054 52.348
202603 49.591 330.213 50.153
202606 53.775 333.952 53.775

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is DaVita (DVA) Overvalued in 2026?

Based on GuruFocus' analysis, DaVita stock appears to be undervalued. The current stock price of $183.86 is trading 6.2% below its estimated GF Value™ of $196.07. GuruFocus considers DaVita to be Fairly Valued.

Key valuation signals for DVA:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: $196.07 vs. price of $183.86 (6.2% below fair value)
  • GF Score™: 91/100 with 6 warning signs

No single metric tells the full story. See the DVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DaVita Business Description

Address 2000 16th Street, Denver, CO, USA, 80202
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
91GF Score

Get the complete analysis for DVA

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$183.86
Price
$196.07
GF Value